Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nevirapine”

153 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 153 results

Post-approval studies (Phase 4)Study completedNCT00466180
What this trial is testing

Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients

Who this might be right for
HIV Infections
University Hospital, Caen 62
Not applicableStudy completedNCT00979420
What this trial is testing

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

Who this might be right for
HIV Infections
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT00639938
What this trial is testing

Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 722
Testing effectiveness (Phase 2)Study completedNCT00307151
What this trial is testing

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV

Who this might be right for
HIV Infections
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 452
Testing effectiveness (Phase 2)Study completedNCT00000781
What this trial is testing

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,292
Not applicableStudy completedNCT02191332
What this trial is testing

Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen

Who this might be right for
HIV Infections
Boehringer Ingelheim 147
Not applicableStudy completedNCT00876733
What this trial is testing

Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 605
Large-scale testing (Phase 3)Study completedNCT00002368
What this trial is testing

The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Boehringer Ingelheim 2,000
Large-scale testing (Phase 3)Study completedNCT00234091
What this trial is testing

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Post-approval studies (Phase 4)Study completedNCT00704249
What this trial is testing

VENICE Study Nevirapine Full Dose/Dose Escalation

Who this might be right for
HIV Infections
Clinical Trial Agency of HIV Study Group 80
Not applicableWithdrawnNCT00087464
What this trial is testing

Three Month Course of Anti-HIV Medications for People Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00000747
What this trial is testing

An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00001688
What this trial is testing

A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Ended earlyNCT02116660
What this trial is testing

Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 11
Post-approval studies (Phase 4)Study completedNCT02082652
What this trial is testing

A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy

Who this might be right for
HIVContraception
University of Pittsburgh 60
Not applicableStudy completedNCT03223402
What this trial is testing

Nevirapine + 3TC Based Maintenance Therapy for HIV Infection

Who this might be right for
HIV Infections
Cantonal Hospital of St. Gallen 20
Post-approval studies (Phase 4)Study completedNCT00986063
What this trial is testing

Genotype Based Personalized Prescription of Nevirapine

Who this might be right for
Nevirapine Induced RashNevirapine Induced HepatitisHIV+3 more
Surakameth Mahasirimongkol 1,200
Early research (Phase 1)Study completedNCT00000649
What this trial is testing

An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)

Who this might be right for
HIV Infections
Boehringer Ingelheim 30
Post-approval studies (Phase 4)Study completedNCT00703898
What this trial is testing

Durability of Nevirapine-Based Antiretroviral Regimen

Who this might be right for
HIV Infections
Bamrasnaradura Infectious Diseases Institute 140
Testing effectiveness (Phase 2)Study completedNCT00142337
What this trial is testing

One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

Who this might be right for
HIV Infections
Institut de Recherche pour le Developpement 244
Load More Results